Product Program year 2023 Source: CMS Open Payments

Jzp-441

Open in the dashboard

General payments

$576,375

29 payments

Research payments

$0

0 payments

Through program year 2023, $576,375 in general payments and $0 in research payments were reported against Jzp-441.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2023 General $576,375 29

Breakdown

Who paid General payments · program year 2023
  1. Jazz Pharmaceuticals Inc. $576,375 29 payments
Top recipients General payments · program year 2023
  1. Revati Shreeniwas Pulmonary Disease · Stanford, CA $374,200 65% · 9 payments
  2. Rajesh Sharma Neurology · Jackson, MS $138,300 24% · 8 payments
  3. Marc Levin Ophthalmology · Palo Alto, CA $23,200 4% · 4 payments
  4. Chirag Parikh Nephrology · Baltimore, MD $18,750 3% · 3 payments
  5. Philip Sager Cardiovascular Disease · San Francisco, CA $17,875 3% · 4 payments

The top 5 of 6 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Pulmonary Disease Internal Medicine $374,200 65% · 1 practitioner
  2. Neurology Psychiatry & Neurology $138,300 24% · 1 practitioner
  3. Ophthalmology $23,200 4% · 1 practitioner
  4. Nephrology Internal Medicine $18,750 3% · 1 practitioner
  5. Cardiovascular Disease Internal Medicine $17,875 3% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. California $415,275 72% · 3 recipients
  2. Mississippi $138,300 24% · 1 recipient
  3. Maryland $18,750 3% · 1 recipient
  4. Connecticut $4,050 <1% · 1 recipient

Each share is of general payments naming this product in 2023 where a state was reported.

29 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record